Cargando…

Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach

BACKGROUND: Swertiamarin is the main hepatoprotective component of Swertiapatens and has anti-inflammatory and antioxidation effects. Our previous study showed that it was a potent inhibitor of idiopathic pulmonary fibrosis (IPF) and can regulate the expressions of α-smooth muscle actin (α-SMA) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jun, Zou, Shaoqing, Xiao, Yiwen, Zhu, Du
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557187/ https://www.ncbi.nlm.nih.gov/pubmed/37798725 http://dx.doi.org/10.1186/s12906-023-04171-w

Ejemplares similares

Bioinformatics analysis of differentially expressed genes in hepatocellular carcinoma cells exposed to Swertiamarin
por: Tang, Haoran, et al.
Publicado: (2019)

Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis
por: Qian, Weibin, et al.
Publicado: (2021)

In silico docking studies for designing potent anti-diabetic derivatives of swertiamarin with enzyme HMG COA reductase
por: Bhatt, Jayshil, et al.
Publicado: (2014)

Identification of autophagy-related genes in idiopathic pulmonary fibrosis using bioinformatics methods
por: Sun, Shulei, et al.
Publicado: (2022)

PA03.06. Swertiamarin A novel lead to antidepressants
por: Dharaniyambigai, K, et al.
Publicado: (2013)

Acetylated and propionated derivatives of swertiamarin have anti-adipogenic effects
por: Vaidya, Hitesh B, et al.
Publicado: (2014)

Swertiamarin ameliorates diet-induced obesity by promoting adipose tissue browning and oxidative metabolism in preexisting obese mice: Swertiamarin reverses obesity by enhancing energy expenditure
por: Zhu, Yuqin, et al.
Publicado: (2022)

Identification of Hub Genes and Pathways Associated With Idiopathic Pulmonary Fibrosis via Bioinformatics Analysis
por: Wan, Hanxi, et al.
Publicado: (2021)

Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and Their Association with Lung Cancer by Bioinformatics Analysis
por: Velázquez-Enríquez, Juan Manuel, et al.
Publicado: (2023)

Identification and Validation of Aging-Related Genes in Idiopathic Pulmonary Fibrosis
por: He, Jie, et al.
Publicado: (2022)

The anti-inflammation, anti-oxidative and anti-fibrosis properties of swertiamarin in cigarette smoke exposure-induced prostate dysfunction in rats
por: Chen, Jinglou, et al.
Publicado: (2019)

Using bioinformatics approach identifies key genes and pathways in idiopathic pulmonary fibrosis
por: Xu, Zhongbo, et al.
Publicado: (2020)

Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis
por: Chen, Qianyi, et al.
Publicado: (2022)

Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis
por: Yao, Yuanshan, et al.
Publicado: (2022)

Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis
por: Wang, Enze, et al.
Publicado: (2022)

Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis–related genes and potential therapeutic drugs
por: Zhang, Zhenzhen, et al.
Publicado: (2023)

The molecular mechanism of Ligusticum wallichii for improving idiopathic pulmonary fibrosis: A network pharmacology and molecular docking study
por: Wu, Xiaozheng, et al.
Publicado: (2022)

Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis
por: Zhao, Tianming, et al.
Publicado: (2023)

Identification and validation of metabolism-related hub genes in idiopathic pulmonary fibrosis
por: Zeng, Youjie, et al.
Publicado: (2023)

Bioinformatic identification and analysis of immune-related chromatin regulatory genes as potential biomarkers in idiopathic pulmonary fibrosis
por: Li, Kaixin, et al.
Publicado: (2022)

Bioinformatic analysis of differentially expressed genes and pathways in idiopathic pulmonary fibrosis
por: Li, Nana, et al.
Publicado: (2021)

Identification of the Molecular Subgroups in Idiopathic Pulmonary Fibrosis by Gene Expression Profiles
por: Zhang, Ning, et al.
Publicado: (2021)

Molecular genetics of idiopathic pulmonary fibrosis
por: Mustafin, R.N.
Publicado: (2022)

Underlying Molecular Mechanism and Construction of a miRNA-Gene Network in Idiopathic Pulmonary Fibrosis by Bioinformatics
por: Zheng, Shuping, et al.
Publicado: (2023)

Swertiamarin suppresses proliferation, migration, and invasion of hepatocellular carcinoma cells via negative regulation of FRAT1
por: Xiao, Shufeng, et al.
Publicado: (2020)

Identification of diagnostic gene biomarkers related to immune infiltration in patients with idiopathic pulmonary fibrosis based on bioinformatics strategies
por: Dai, Xiangdong, et al.
Publicado: (2022)

The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—Approaching with Next-Generation Sequencing and Bioinformatics
por: Chang, Wei-An, et al.
Publicado: (2020)

Identification of targetable kinases in idiopathic pulmonary fibrosis
por: Higo, Hisao, et al.
Publicado: (2022)

Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
por: Zhang, Yihang, et al.
Publicado: (2023)

Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score
por: Karatzas, E., et al.
Publicado: (2017)

Integrative bioinformatics and validation studies reveal KDM6B and its associated molecules as crucial modulators in Idiopathic Pulmonary Fibrosis
por: Chen, Anning, et al.
Publicado: (2023)

Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics
por: Yan, Feng, et al.
Publicado: (2017)

Identification and immunological characterization of cuproptosis-related molecular clusters in idiopathic pulmonary fibrosis disease
por: Shi, Xuefeng, et al.
Publicado: (2023)

Incorporating genetics into the identification and treatment of Idiopathic Pulmonary Fibrosis
por: Mathai, Susan K., et al.
Publicado: (2015)

Identification and validation of autophagy-related gene expression for predicting prognosis in patients with idiopathic pulmonary fibrosis
por: Huang, Guichuan, et al.
Publicado: (2022)

Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review
por: Hou, Yuan, et al.
Publicado: (2023)

Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin – A Promising Natural Lead for New Drug Discovery and Development
por: Muhamad Fadzil, Nur Sakinah, et al.
Publicado: (2021)

The Effects of Epigallocatechin Gallate (EGCG) on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—A Next-Generation Sequencing and Bioinformatic Approach
por: Tsai, Ming-Ju, et al.
Publicado: (2019)

Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
por: Phan, Thị Hằng Giang, et al.
Publicado: (2020)

Integrated analysis of the molecular mechanisms in idiopathic pulmonary fibrosis
por: Zhu, Ke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5tpjfqsmo237chhtib46pbitvs